Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Pfizer researchers present selective inhibitors of urokinase and their use

June 1, 1999

No Comments

Novel compounds for vitamin D-dependent disorders in development at Roche

May 31, 1999

No Comments

AxyS initiates phase II human clinical trials of APC-2059 for treatment of psoriasis

May 28, 1999

No Comments

Antiacne drug candidate available for licensing from Shire

May 27, 1999

No Comments

Biogen's Amevive shows excellent results in phase II psoriasis study

May 27, 1999

No Comments

FDA advisory panel review of Levulan to be rescheduled

May 24, 1999

No Comments

Compounds for promoting hair growth or regrowth disclosed by Shiseido

May 24, 1999

No Comments

OSI and Pfizer enter license agreement to develop psoriasis treatment

May 24, 1999

No Comments

Gliatech files IDE for ADCON-A antiadhesion barrier

May 13, 1999

No Comments

New antiinflammatory/analgesic agents with both topical and oral activity

May 10, 1999

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Dermatologic
RSS

Pfizer researchers present selective inhibitors of urokinase and their use

Novel compounds for vitamin D-dependent disorders in development at Roche

AxyS initiates phase II human clinical trials of APC-2059 for treatment of psoriasis

Antiacne drug candidate available for licensing from Shire

Biogen's Amevive shows excellent results in phase II psoriasis study

FDA advisory panel review of Levulan to be rescheduled

Compounds for promoting hair growth or regrowth disclosed by Shiseido

OSI and Pfizer enter license agreement to develop psoriasis treatment

Gliatech files IDE for ADCON-A antiadhesion barrier

New antiinflammatory/analgesic agents with both topical and oral activity

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Proteomics study explores how protein changes influence disease

Abbvie and Simcere enter a $1B T-cell engager deal

Dermatologic RSS

Dermatologic
RSS